TreeWAS – Variant ID: rs9825379

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
F32 Depressive episode	0.271	0.729
F32.2 Severe depressive episode without psychotic symptoms	0.266	0.734
F32.9 Depressive episode, unspecified	0.264	0.736
F30-F39 Mood [affective] disorders	0.259	0.741
F33 Recurrent depressive disorder	0.249	0.751
F30 Manic episode	0.220	0.780
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.218	0.782
F32.3 Severe depressive episode with psychotic symptoms	0.216	0.784
F33.9 Recurrent depressive disorder, unspecified	0.214	0.786
F32.1 Moderate depressive episode	0.204	0.796
F33.1 Recurrent depressive disorder, current episode moderate	0.200	0.800
Q20-Q28 Congenital malformations of the circulatory system	0.200	0.800
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.199	0.801
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.198	0.802
F32.8 Other depressive episodes	0.195	0.805
F30.0 Hypomania	0.193	0.807
Q60-Q64 Congenital malformations of the urinary system	0.186	0.814
F39 Unspecified mood [affective] disorder	0.186	0.814
F38 Other mood [affective] disorders	0.186	0.814
F34 Persistent mood [affective] disorders	0.186	0.814
Q28 Other congenital malformations of circulatory system	0.184	0.816
Q21 Congenital malformations of cardiac septa	0.180	0.820
F33.8 Other recurrent depressive disorders	0.179	0.821
F33.4 Recurrent depressive disorder, currently in remission	0.179	0.821
F33.0 Recurrent depressive disorder, current episode mild	0.179	0.821
T36-T50 Poisoning by drugs, medicaments and biological substances	0.177	0.823
Q80-Q89 Other congenital malformations	0.177	0.823
F32.0 Mild depressive episode	0.176	0.823
Q28.2 Arteriovenous malformation of cerebral vessels	0.173	0.827
Q61 Cystic kidney disease	0.171	0.829
Q27 Other congenital malformations of peripheral vascular system	0.170	0.830
Q21.1 Atrial septal defect	0.168	0.832
Chapter V Mental and behavioural disorders	0.165	0.835
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.165	0.835
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.163	0.837
Q50-Q56 Congenital malformations of genital organs	0.163	0.837
F31 Bipolar affective disorder	0.163	0.837
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.160	0.840
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.159	0.841
F30.9 Manic episode, unspecified	0.158	0.842
F30.8 Other manic episodes	0.158	0.842
F30.2 Mania with psychotic symptoms	0.158	0.842
F30.1 Mania without psychotic symptoms	0.158	0.842
Q00-Q07 Congenital malformations of the nervous system	0.158	0.842
N40 Hyperplasia of prostate	0.157	0.843
T39.0 Salicylates	0.156	0.844
Q23 Congenital malformations of aortic and mitral valves	0.156	0.844
Q61.3 Polycystic kidney, unspecified	0.155	0.845
Q24 Other congenital malformations of heart	0.152	0.848
F40-F48 Neurotic, stress-related and somatoform disorders	0.151	0.849
Q82 Other congenital malformations of skin	0.149	0.851
Q27.3 Peripheral arteriovenous malformation	0.149	0.851
T46 Poisoning by agents primarily affecting the cardiovascular system	0.148	0.852
Q85 Phakomatoses, not elsewhere classified	0.147	0.853
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.147	0.853
Q38-Q45 Other congenital malformations of the digestive system	0.147	0.853
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.147	0.853
Q60 Renal agenesis and other reduction defects of kidney	0.147	0.853
# Top node	0.147	0.853
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.145	0.855
T43.5 Other and unspecified antipsychotics and neuroleptics	0.145	0.855
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.144	0.856
S00-S09 Injuries to the head	0.144	0.856
Q63 Other congenital malformations of kidney	0.144	0.856
Chapter XXII Codes for special purposes	0.144	0.856
Q26 Congenital malformations of great veins	0.143	0.857
Q25 Congenital malformations of great arteries	0.143	0.857
Q22 Congenital malformations of pulmonary and tricuspid valves	0.143	0.857
Q20 Congenital malformations of cardiac chambers and connexions	0.143	0.857
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.143	0.857
Q35-Q37 Cleft lip and cleft palate	0.143	0.857
Q30-Q34 Congenital malformations of the respiratory system	0.143	0.857
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.143	0.857
Chapter XV Pregnancy, childbirth and the puerperium	0.142	0.858
T43.2 Other and unspecified antidepressants	0.142	0.858
Q61.2 Polycystic kidney, adult type	0.140	0.860
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.139	0.861
S06 Intracranial injury	0.137	0.862
N40-N51 Diseases of male genital organs	0.135	0.865
Q64 Other congenital malformations of urinary system	0.134	0.866
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter	0.134	0.866
S01 Open wound of head	0.134	0.866
U51 Admission status on psychiatric patients	0.134	0.866
F34.9 Persistent mood [affective] disorder, unspecified	0.133	0.866
F34.8 Other persistent mood [affective] disorders	0.133	0.866
F34.1 Dysthymia	0.133	0.866
F34.0 Cyclothymia	0.133	0.866
F38.8 Other specified mood [affective] disorders	0.133	0.866
F38.1 Other recurrent mood [affective] disorders	0.133	0.866
F38.0 Other single mood [affective] disorders	0.133	0.866
F41 Other anxiety disorders	0.133	0.867
O20-O29 Other maternal disorders predominantly related to pregnancy	0.133	0.867
U80 Agent resistant to penicillin and related antibiotics	0.133	0.867
O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems	0.132	0.868
Q51 Congenital malformations of uterus and cervix	0.132	0.868
Q07 Other congenital malformations of nervous system	0.132	0.868
Q28.9 Congenital malformation of circulatory system, unspecified	0.132	0.868
Q28.8 Other specified congenital malformations of circulatory system	0.132	0.868
Q28.3 Other malformations of cerebral vessels	0.132	0.868
Q28.1 Other malformations of precerebral vessels	0.132	0.868
Q28.0 Arteriovenous malformation of precerebral vessels	0.132	0.868
Q54 Hypospadias	0.132	0.868
T45.1 Antineoplastic and immunosuppressive drugs	0.131	0.868
T45.5 Anticoagulants	0.131	0.869
Chapter XX External causes of morbidity and mortality	0.131	0.869
Q82.8 Other specified congenital malformations of skin	0.130	0.870
Q21.9 Congenital malformation of cardiac septum, unspecified	0.129	0.871
Q21.8 Other congenital malformations of cardiac septa	0.129	0.871
Q21.4 Aortopulmonary septal defect	0.129	0.871
Q21.3 Tetralogy of Fallot	0.129	0.871
Q21.2 Atrioventricular septal defect	0.129	0.871
F80-F89 Disorders of psychological development	0.129	0.871
O36 Maternal care for other known or suspected foetal problems	0.129	0.871
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.128	0.872
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.127	0.872
U51.0 Not Previously admitted to a psyciatric hospital	0.127	0.873
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.127	0.873
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.127	0.873
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.127	0.873
T41 Poisoning by anaesthetics and therapeutic gases	0.127	0.873
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.127	0.873
T36 Poisoning by systemic antibiotics	0.127	0.873
Q89 Other congenital malformations, not elsewhere classified	0.127	0.873
Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified	0.127	0.873
Q84 Other congenital malformations of integument	0.127	0.873
Q83 Congenital malformations of breast	0.127	0.873
Q81 Epidermolysis bullosa	0.127	0.873
Q80 Congenital ichthyosis	0.127	0.873
Q85.0 Neurofibromatosis (nonmalignant)	0.126	0.873
Q87 Other specified congenital malformation syndromes affecting multiple systems	0.126	0.874
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.126	0.874
S06.6 Traumatic subarachnoid haemorrhage	0.126	0.874
T43.0 Tricyclic and tetracyclic antidepressants	0.126	0.874
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.125	0.874
F44 Dissociative [conversion] disorders	0.125	0.875
Chapter VII Diseases of the eye and adnexa	0.125	0.875
Q23.1 Congenital insufficiency of aortic valve	0.125	0.875
O26 Maternal care for other conditions predominantly related to pregnancy	0.124	0.876
T45.0 Antiallergic and antiemetic drugs	0.124	0.876
F41.9 Anxiety disorder, unspecified	0.124	0.876
Chapter XIV Diseases of the genitourinary system	0.123	0.877
Q61.9 Cystic kidney disease, unspecified	0.123	0.877
Q61.8 Other cystic kidney diseases	0.123	0.877
Q61.5 Medullary cystic kidney	0.123	0.877
Q61.4 Renal dysplasia	0.123	0.877
Q61.1 Polycystic kidney, infantile type	0.123	0.877
F99-F99 Unspecified mental disorder	0.123	0.877
Q27.9 Congenital malformation of peripheral vascular system, unspecified	0.122	0.878
Q27.8 Other specified congenital malformations of peripheral vascular system	0.122	0.878
Q27.4 Congenital phlebectasia	0.122	0.878
Q27.2 Other congenital malformations of renal artery	0.122	0.878
Q27.1 Congenital renal artery stenosis	0.122	0.878
Q27.0 Congenital absence and hypoplasia of umbilical artery	0.122	0.878
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.122	0.878
O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium	0.122	0.878
H55-H59 Other disorders of eye and adnexa	0.121	0.879
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.120	0.880
F40 Phobic anxiety disorders	0.120	0.880
T46.4 Angiotensin-converting-enzyme inhibitors	0.120	0.880
S06.2 Diffuse brain injury	0.120	0.880
Q61.0 Congenital single renal cyst	0.120	0.880
T42.4 Benzodiazepines	0.120	0.880
F31.0 Bipolar affective disorder, current episode hypomanic	0.119	0.880
H10-H13 Disorders of conjunctiva	0.120	0.880
Q21.0 Ventricular septal defect	0.119	0.881
S01.4 Open wound of cheek and temporomandibular area	0.119	0.881
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.119	0.881
F70-F79 Mental retardation	0.119	0.881
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.119	0.881
S01.3 Open wound of ear	0.119	0.881
T43.9 Psychotropic drug, unspecified	0.118	0.881
T43.8 Other psychotropic drugs, not elsewhere classified	0.118	0.881
T43.6 Psychostimulants with abuse potential	0.118	0.881
T43.4 Butyrophenone and thioxanthene neuroleptics	0.118	0.881
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.118	0.881
U80.1 Methicillin resistant agent	0.118	0.882
N43 Hydrocele and spermatocele	0.118	0.882
T43.3 Phenothiazine antipsychotics and neuroleptics	0.118	0.882
O36.4 Maternal care for intra-uterine death	0.118	0.882
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.118	0.882
Q24.8 Other specified congenital malformations of heart	0.117	0.883
S90-S99 Injuries to the ankle and foot	0.117	0.883
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.117	0.883
T39.4 Antirheumatics, not elsewhere classified	0.117	0.883
T39.2 Pyrazolone derivatives	0.117	0.883
Q56 Indeterminate sex and pseudohermaphroditism	0.117	0.883
Q55 Other congenital malformations of male genital organs	0.117	0.883
Q53 Undescended testicle	0.117	0.883
Q52 Other congenital malformations of female genitalia	0.117	0.883
F31.6 Bipolar affective disorder, current episode mixed	0.117	0.883
F31.8 Other bipolar affective disorders	0.117	0.883
F31.7 Bipolar affective disorder, currently in remission	0.117	0.883
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.117	0.883
S02 Fracture of skull and facial bones	0.117	0.883
N60-N64 Disorders of breast	0.117	0.883
Y88 Sequelae of surgical and medical care as external cause	0.117	0.883
H11 Other disorders of conjunctiva	0.116	0.884
F41.2 Mixed anxiety and depressive disorder	0.116	0.884
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.115	0.884
T46.1 Calcium-channel blockers	0.115	0.884
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.115	0.885
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.115	0.885
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.115	0.885
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.115	0.885
T42.5 Mixed antiepileptics, not elsewhere classified	0.115	0.885
T42.3 Barbiturates	0.115	0.885
T42.2 Succinimides and oxazolidinediones	0.115	0.885
T42.1 Iminostilbenes	0.115	0.885
T42.0 Hydantoin derivatives	0.115	0.885
S05 Injury of eye and orbit	0.115	0.885
Q60.2 Renal agenesis, unspecified	0.114	0.885
Y88.3 Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient or of later complication, without mention of misadventure at the time of the procedure	0.115	0.885
F42 Obsessive-compulsive disorder	0.114	0.886
O94-O99 Other obstetric conditions, not elsewhere classified	0.114	0.886
T45.9 Primarily systemic and haematological agent, unspecified	0.114	0.886
T45.8 Other primarily systemic and haematological agents	0.114	0.886
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.114	0.886
T45.6 Fibrinolysis-affecting drugs	0.114	0.886
T45.4 Iron and its compounds	0.114	0.886
T45.3 Enzymes, not elsewhere classified	0.114	0.886
T45.2 Vitamins, not elsewhere classified	0.114	0.886
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.114	0.886
N63 Unspecified lump in breast	0.114	0.886
Q07.0 Arnold-Chiari syndrome	0.114	0.886
Q06 Other congenital malformations of spinal cord	0.113	0.886
Q04 Other congenital malformations of brain	0.113	0.886
Q03 Congenital hydrocephalus	0.113	0.886
Q01 Encephalocele	0.113	0.886
Q00 Anencephaly and similar malformations	0.113	0.886
Q02 Microcephaly	0.113	0.886
O43 Placental disorders	0.112	0.888
W50-W64 Exposure to animate mechanical forces	0.112	0.888
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.112	0.888
Q23.8 Other congenital malformations of aortic and mitral valves	0.112	0.888
Q23.4 Hypoplastic left heart syndrome	0.112	0.888
Q23.3 Congenital mitral insufficiency	0.112	0.888
Q23.2 Congenital mitral stenosis	0.112	0.888
Q23.0 Congenital stenosis of aortic valve	0.112	0.888
N60 Benign mammary dysplasia	0.112	0.888
O47 False labour	0.112	0.888
S40-S49 Injuries to the shoulder and upper arm	0.112	0.888
H59.8 Other postprocedural disorders of eye and adnexa	0.112	0.888
H11.4 Other conjunctival vascular disorders and cysts	0.112	0.888
O26.8 Other specified pregnancy-related conditions	0.111	0.889
S01.5 Open wound of lip and oral cavity	0.111	0.889
Q24.9 Congenital malformation of the heart, unspecified	0.111	0.889
V40-V49 Car occupant injured in transport accident	0.111	0.889
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.111	0.889
Q63.1 Lobulated, fused and horseshoe kidney	0.110	0.889
Q38 Other congenital malformations of tongue, mouth and pharynx	0.110	0.890
Q60.0 Renal agenesis, unilateral	0.110	0.890
S06.5 Traumatic subdural haemorrhage	0.110	0.890
Q24.6 Congenital heart block	0.109	0.890
Q24.5 Malformation of coronary vessels	0.109	0.890
Q24.4 Congenital subaortic stenosis	0.109	0.890
Q24.3 Pulmonary infundibular stenosis	0.109	0.890
Q24.2 Cor triatriatum	0.109	0.890
Q24.1 Levocardia	0.109	0.890
Q24.0 Dextrocardia	0.109	0.890
T20-T25 Burns and corrosions of external body surface, specified by site	0.109	0.890
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.108	0.891
N60.1 Diffuse cystic mastopathy	0.108	0.892
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.108	0.892
T40.6 Other and unspecified narcotics	0.108	0.892
Q65 Congenital deformities of hip	0.108	0.892
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.108	0.892
N10-N16 Renal tubulo-interstitial diseases	0.108	0.892
F48 Other neurotic disorders	0.108	0.892
U80.0 Penicillin resistant agent	0.108	0.892
Q05 Spina bifida	0.108	0.892
O85-O92 Complications predominantly related to the puerperium	0.108	0.892
S01.1 Open wound of eyelid and periocular area	0.108	0.892
S06.20 Diffuse brain injury (without open intracranial wound)	0.108	0.892
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.107	0.892
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.107	0.893
Q82.9 Congenital malformation of skin, unspecified	0.107	0.893
Q82.5 Congenital nonneoplastic naevus	0.107	0.893
Q82.4 Ectodermal dysplasia (anhidrotic)	0.107	0.893
Q82.3 Incontinentia pigmenti	0.107	0.893
Q82.2 Mastocytosis	0.107	0.893
Q82.1 Xeroderma pigmentosum	0.107	0.893
Q82.0 Hereditary lymphoedema	0.107	0.893
F44.4 Dissociative motor disorders	0.107	0.893
X10-X19 Contact with heat and hot substances	0.107	0.893
Q44 Congenital malformations of gallbladder, bile ducts and liver	0.107	0.893
N43.3 Hydrocele, unspecified	0.107	0.893
Q63.0 Accessory kidney	0.107	0.893
Q51.2 Other doubling of uterus	0.106	0.894
T66-T78 Other and unspecified effects of external causes	0.106	0.894
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.106	0.894
T46.8 Antivaricose drugs, including sclerosing agents	0.106	0.894
T46.7 Peripheral vasodilators	0.106	0.894
T46.5 Other antihypertensive drugs, not elsewhere classified	0.106	0.894
T46.3 Coronary vasodilators, not elsewhere classified	0.106	0.894
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.106	0.894
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.106	0.894
F60-F69 Disorders of adult personality and behaviour	0.106	0.894
Q54.0 Hypospadias, balanic	0.106	0.894
Q85.9 Phakomatosis, unspecified	0.106	0.894
Q85.8 Other phakomatoses, not elsewhere classified	0.106	0.894
Q85.1 Tuberous sclerosis	0.106	0.894
O36.8 Maternal care for other specified foetal problems	0.106	0.894
Q45 Other congenital malformations of digestive system	0.105	0.894
Q42 Congenital absence, atresia and stenosis of large intestine	0.105	0.894
Q41 Congenital absence, atresia and stenosis of small intestine	0.105	0.894
Q40 Other congenital malformations of upper alimentary tract	0.105	0.894
Q39 Congenital malformations of oesophagus	0.105	0.894
T33-T35 Frostbite	0.105	0.894
T26-T28 Burns and corrosions confined to eye and internal organs	0.105	0.894
W20-W49 Exposure to inanimate mechanical forces	0.105	0.894
Q60.6 Potter's syndrome	0.105	0.895
Q60.5 Renal hypoplasia, unspecified	0.105	0.895
Q60.4 Renal hypoplasia, bilateral	0.105	0.895
Q60.3 Renal hypoplasia, unilateral	0.105	0.895
Q60.1 Renal agenesis, bilateral	0.105	0.895
Chapter XVI Certain conditions originating in the perinatal period	0.105	0.895
T00-T07 Injuries involving multiple body regions	0.105	0.895
O26.2 Pregnancy care of habitual aborter	0.105	0.895
S01.7 Multiple open wounds of head	0.105	0.895
U80.8 Agent resistant to other penicillin-related antibiotic	0.105	0.895
S91 Open wound of ankle and foot	0.105	0.895
N41 Inflammatory diseases of prostate	0.105	0.895
U81 Agent resistant to vancomycin and related antibiotics	0.105	0.895
S50-S59 Injuries to the elbow and forearm	0.105	0.895
O14 Gestational [pregnancy-induced] hypertension with significant proteinuria	0.105	0.895
O20 Haemorrhage in early pregnancy	0.104	0.896
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.104	0.896
Q79 Congenital malformations of musculoskeletal system, not elsewhere classified	0.104	0.896
Q78 Other osteochondrodysplasias	0.104	0.896
Q77 Osteochondrodysplasia with defects of growth of tubular bones and spine	0.104	0.896
Q75 Other congenital malformations of skull and face bones	0.104	0.896
Q74 Other congenital malformations of limb(s)	0.104	0.896
Q73 Reduction defects of unspecified limb	0.104	0.896
Q72 Reduction defects of lower limb	0.104	0.896
Q71 Reduction defects of upper limb	0.104	0.896
Q70 Syndactyly	0.104	0.896
Q69 Polydactyly	0.104	0.896
Q68 Other congenital musculoskeletal deformities	0.104	0.896
Q67 Congenital musculoskeletal deformities of head, face, spine and chest	0.104	0.896
Q66 Congenital deformities of feet	0.104	0.896
N46 Male infertility	0.104	0.896
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.103	0.896
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.103	0.896
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.103	0.896
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.103	0.896
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.103	0.896
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.103	0.896
T44.1 Other parasympathomimetics [cholinergics]	0.103	0.896
T44.0 Anticholinesterase agents	0.103	0.896
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.103	0.896
Q43 Other congenital malformations of intestine	0.103	0.896
S08 Traumatic amputation of part of head	0.103	0.896
S07 Crushing injury of head	0.103	0.896
S04 Injury of cranial nerves	0.103	0.896
S03 Dislocation, sprain and strain of joints and ligaments of head	0.103	0.896
O36.0 Maternal care for rhesus isoimmunisation	0.103	0.897
Q63.9 Congenital malformation of kidney, unspecified	0.103	0.897
Q63.8 Other specified congenital malformations of kidney	0.103	0.897
Q63.3 Hyperplastic and giant kidney	0.103	0.897
Q63.2 Ectopic kidney	0.103	0.897
Q20.9 Congenital malformation of cardiac chambers and connexions, unspecified	0.103	0.897
Q20.8 Other congenital malformations of cardiac chambers and connexions	0.103	0.897
Q20.6 Isomerism of atrial appendages	0.103	0.897
Q20.5 Discordant atrioventricular connexion	0.103	0.897
Q20.4 Double inlet ventricle	0.103	0.897
Q20.3 Discordant ventriculoarterial connexion	0.103	0.897
Q20.2 Double outlet left ventricle	0.103	0.897
Q20.1 Double outlet right ventricle	0.103	0.897
Q20.0 Common arterial trunk	0.103	0.897
Q22.9 Congenital malformation of tricuspid valve, unspecified	0.103	0.897
Q22.8 Other congenital malformations of tricuspid valve	0.103	0.897
Q22.6 Hypoplastic right heart syndrome	0.103	0.897
Q22.5 Ebstein's anomaly	0.103	0.897
Q22.4 Congenital tricuspid stenosis	0.103	0.897
Q22.3 Other congenital malformations of pulmonary valve	0.103	0.897
Q22.2 Congenital pulmonary valve insufficiency	0.103	0.897
Q22.1 Congenital pulmonary valve stenosis	0.103	0.897
Q22.0 Pulmonary valve atresia	0.103	0.897
Q25.9 Congenital malformation of great arteries, unspecified	0.103	0.897
Q25.8 Other congenital malformations of great arteries	0.103	0.897
Q25.7 Other congenital malformations of pulmonary artery	0.103	0.897
Q25.6 Stenosis of pulmonary artery	0.103	0.897
Q25.5 Atresia of pulmonary artery	0.103	0.897
Q25.4 Other congenital malformations of aorta	0.103	0.897
Q25.3 Stenosis of aorta	0.103	0.897
Q25.2 Atresia of aorta	0.103	0.897
Q25.1 Coarctation of aorta	0.103	0.897
Q25.0 Patent ductus arteriosus	0.103	0.897
Q26.9 Congenital malformation of great vein, unspecified	0.103	0.897
Q26.8 Other congenital malformations of great veins	0.103	0.897
Q26.6 Portal vein-hepatic artery fistula	0.103	0.897
Q26.5 Anomalous portal venous connexion	0.103	0.897
Q26.4 Anomalous pulmonary venous connexion, unspecified	0.103	0.897
Q26.3 Partial anomalous pulmonary venous connexion	0.103	0.897
Q26.2 Total anomalous pulmonary venous connexion	0.103	0.897
Q26.1 Persistent left superior vena cava	0.103	0.897
Q26.0 Congenital stenosis of vena cava	0.103	0.897
S06.9 Intracranial injury, unspecified	0.103	0.897
Q34 Other congenital malformations of respiratory system	0.103	0.897
Q33 Congenital malformations of lung	0.103	0.897
Q32 Congenital malformations of trachea and bronchus	0.103	0.897
Q31 Congenital malformations of larynx	0.103	0.897
Q30 Congenital malformations of nose	0.103	0.897
Q37 Cleft palate with cleft lip	0.103	0.897
Q36 Cleft lip	0.103	0.897
Q35 Cleft palate	0.103	0.897
Q99 Other chromosome abnormalities, not elsewhere classified	0.103	0.897
Q98 Other sex chromosome abnormalities, male phenotype, not elsewhere classified	0.103	0.897
Q97 Other sex chromosome abnormalities, female phenotype, not elsewhere classified	0.103	0.897
Q96 Turner's syndrome	0.103	0.897
Q95 Balanced rearrangements and structural markers, not elsewhere classified	0.103	0.897
Q93 Monosomies and deletions from the autosomes, not elsewhere classified	0.103	0.897
Q92 Other trisomies and partial trisomies of the autosomes, not elsewhere classified	0.103	0.897
Q91 Edwards' syndrome and Patau's syndrome	0.103	0.897
Q90 Down's syndrome	0.103	0.897
X60-X84 Intentional self-harm	0.103	0.897
U50 Level of care administered to neonates	0.102	0.898
U07 Emergency use of U07	0.102	0.898
U06 Emergency use of U06	0.102	0.898
U04 Severe acute respiratory syndrome [SARS]	0.102	0.898
U52 First in a series of a regular day/night admissions	0.102	0.898
H57 Other disorders of eye and adnexa	0.102	0.898
O36.3 Maternal care for signs of foetal hypoxia	0.102	0.898
T15-T19 Effects of foreign body entering through natural orifice	0.102	0.898
N42 Other disorders of prostate	0.102	0.898
S01.2 Open wound of nose	0.102	0.898
X58-X59 Accidental exposure to other and unspecified factors	0.101	0.899
O80-O84 Delivery	0.101	0.899
S02.6 Fracture of mandible	0.101	0.899
Q76 Congenital malformations of spine and bony thorax	0.101	0.899
Q18 Other congenital malformations of face and neck	0.101	0.899
O36.5 Maternal care for poor foetal growth	0.101	0.899
O43.8 Other placental disorders	0.101	0.899
X40-X49 Accidental poisoning by and exposure to noxious substances	0.100	0.900
O47.1 False labour at or after 37 completed weeks of gestation	0.100	0.900
Q17 Other congenital malformations of ear	0.100	0.900
Q16 Congenital malformations of ear causing impairment of hearing	0.100	0.900
Q15 Other congenital malformations of eye	0.100	0.900
Q14 Congenital malformations of posterior segment of eye	0.100	0.900
Q13 Congenital malformations of anterior segment of eye	0.100	0.900
Q11 Anophthalmos, microphthalmos and macrophthalmos	0.100	0.900
Q10 Congenital malformations of eyelid, lachrymal apparatus and orbit	0.100	0.900
Q51.3 Bicornate uterus	0.100	0.900
S60-S69 Injuries to the wrist and hand	0.100	0.900
V20-V29 Motorcycle rider injured in transport accident	0.100	0.900
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria	0.100	0.900
Q54.9 Hypospadias, unspecified	0.099	0.901
F81 Specific developmental disorders of scholastic skills	0.099	0.901
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.099	0.901
S06.7 Intracranial injury with prolonged coma	0.099	0.901
S06.4 Epidural haemorrhage	0.099	0.901
S06.1 Traumatic cerebral oedema	0.099	0.901
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.099	0.901
O21 Excessive vomiting in pregnancy	0.098	0.901
O36.9 Maternal care for foetal problem, unspecified	0.098	0.901
F40.2 Specific (isolated) phobias	0.098	0.902
O41 Other disorders of amniotic fluid and membranes	0.098	0.902
Y60-Y69 Misadventures to patients during surgical and medical care	0.098	0.902
T39.1 4-Aminophenol derivatives	0.098	0.902
Y85 Sequelae of transport accidents	0.098	0.902
O30 Multiple gestation	0.097	0.903
X50-X57 Overexertion, travel and privation	0.097	0.903
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.097	0.903
O28 Abnormal findings on antenatal screening of mother	0.097	0.903
F84 Pervasive developmental disorders	0.097	0.903
V48 Car occupant injured in noncollision transport accident	0.097	0.903
O24 Diabetes mellitus in pregnancy	0.097	0.903
O40 Polyhydramnios	0.097	0.903
S91.3 Open wound of other parts of foot	0.097	0.903
F43 Reaction to severe stress, and adjustment disorders	0.097	0.903
N51 Disorders of male genital organs in diseases classified elsewhere	0.097	0.903
N44 Torsion of testis	0.097	0.903
U51.1 Previously admitted to a psychiatric hospital of the provider	0.097	0.903
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.097	0.903
Q62.8 Other congenital malformations of ureter	0.096	0.904
Q62.7 Congenital vesico-uretero-renal reflux	0.096	0.904
Q62.6 Malposition of ureter	0.096	0.904
Q62.5 Duplication of ureter	0.096	0.904
Q62.4 Agenesis of ureter	0.096	0.904
Q62.3 Other obstructive defects of renal pelvis and ureter	0.096	0.904
Q62.2 Congenital megaloureter	0.096	0.904
Q62.1 Atresia and stenosis of ureter	0.096	0.904
Q62.0 Congenital hydronephrosis	0.096	0.904
Q64.9 Congenital malformation of urinary system, unspecified	0.096	0.904
Q64.8 Other specified congenital malformations of urinary system	0.096	0.904
Q64.7 Other congenital malformations of bladder and urethra	0.096	0.904
Q64.6 Congenital diverticulum of bladder	0.096	0.904
Q64.5 Congenital absence of bladder and urethra	0.096	0.904
Q64.4 Malformation of urachus	0.096	0.904
Q64.3 Other atresia and stenosis of urethra and bladder neck	0.096	0.904
Q64.2 Congenital posterior urethral valves	0.096	0.904
Q64.1 Exstrophy of urinary bladder	0.096	0.904
Q64.0 Epispadias	0.096	0.904
U51.2 Previously admitted to a psychiatric hospital of another provider	0.096	0.904
F41.8 Other specified anxiety disorders	0.096	0.904
F41.3 Other mixed anxiety disorders	0.096	0.904
V80-V89 Other land transport accidents	0.096	0.904
Q12 Congenital lens malformations	0.095	0.904
W29 Contact with other powered hand tools and household machinery	0.096	0.904
O29 Complications of anaesthesia during pregnancy	0.095	0.904

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations